# Preemptive Intravenous Micro-dose Dexmedetomidine to Prevent Emergence Agitation in Adult Patients Undergoing Septoplasty Surgeries

> **NCT07302815** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Tanta University** · enrollment: 120 (estimated)

## Conditions studied

- Emergence Agitation

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT07302815
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2026-01-10
- **Primary completion:** 2026-07-10
- **Final completion:** 2026-07-30
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07302815

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07302815, "Preemptive Intravenous Micro-dose Dexmedetomidine to Prevent Emergence Agitation in Adult Patients Undergoing Septoplasty Surgeries". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT07302815. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*